Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat


      An investigation was made of the effect of Momordica charantia fruit juice on the distribution and number of α, β and δ cells in the pancreas of streptozotocin (STZ)-induced diabetic rats using immunohistochemical methods. The results indicated that there was a significant (Student's t-test, P<0.004) increase in the number of β cells in M. charantia-treated animals when compared with untreated diabetics, however, their number was still significantly less than that obtained for normal rats. There was also a significant (P<0.006) increase in the number of δ cells in STZ-diabetic rats compared to non-diabetic rats. This increase in the number of δ cells was not affected by M. charantia treatment. The number of α cells did not change significantly in M. charantia-treated rats when compared with untreated diabetic rats. Our results suggest that oral feeding of M. charantia fruit juice may have a role in the renewal of β cells in STZ-diabetic rats or alternately may permit the recovery of partially destroyed β cells.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. E.H. Karunanayake, K.H. Tennekoon, Search of novel hypoglycaemic agents from medicinal plants, in: A.K. Sharma (Ed.), Diabetes Mellitus and its Complications—An update, Macmillan India, 1993, pp. 192–196.

        • Lin J.Y.
        • Hou M.J.
        • Chen Y.C.
        Isolation of toxic and non-toxic lectins from the bitter pear lemon Momorclica charantia Linn.
        Toxicon. 1978; 16: 653-659
        • Barbieri L.
        • Lorenzoni E.
        • Stirpe F.
        Inhibition of protein synthesis in vitro by a lectin from Momordica charantia and by other haemagglutinins.
        Biochem. J. 1979; 182: 633-635
        • Clafin A.J.
        • Vesely D.L.
        • Hudson J.L.
        • et al.
        Inhibition of growth and adenylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviate).
        Proc. Natl. Acad. Sci. USA. 1978; 75: 989-993
        • Jilka C.
        • Strifler B.
        • Fortner G.W.
        • Hays E.F.
        • Takemoto D.J.
        Invivo antitumor activity of the bitter melon (Momordica charantia).
        Cancer Res. 1983; 43: 5151-5155
        • Morton J.F.
        The balsam pear—an edible, medicinal and toxic plant.
        Econom Bot. 1967; 21: 57
        • Welihinda J.
        • Karunanayake E.H.
        • Sheriff M.H.R.
        • Jayasinghe K.S.A.
        Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.
        J. Ethnopharmacol. 1986; 17: 277-282
        • Welihinda J.
        • Arvidson G.
        • Gylfe E.
        • Hellman B.
        • Karlesson E.
        The insulin releasing activity of the tropical plant Momordica charantia.
        Acta Biol. Med. Germ. 1982; 41: 1229-1240
        • Karunanayake E.H.
        • Welihinda J.
        • Sirimanne S.R.
        • Sinnadorai G.
        Oral hypoglycaemic activity of some medicinal plants of Sri Lanka.
        J. Ethnopharmacol. 1984; 11: 223-231
        • Day C.
        • Cartwright T.
        • Provost J.
        • Bailey C.J.
        Hypoglycaemic effect of Momordica charantia extracts.
        Planta Med. 1990; 56: 426-429
        • Leatherdale B.A.
        • Panesar R.K.
        • Singh G.
        • Atkins T.W.
        • Bailey C.J.
        • Bignell A.H.
        Improvement in glucose tolerance due to Momordica charantia (Karela).
        Br. Med. J. 1981; 282: 1823-1824
        • Baldwa V.S.
        • Bhandari C.M.
        • Pangaria A.
        • Goyal R.K.
        Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source.
        Uppsala J. Med. Sci. 1977; 82: 39-41
        • Sharma A.K.
        • Ahmed I.
        • Tadayyon M.
        • et al.
        The beneficial effects of Momordica charantia fruit juice on streptozotocin induced diabetes and hypertension in rats.
        Int. J. Diabetes. 1995; 4: 29-38
        • Zamboni L.
        • de Martino C.
        Buffered picric acid-formaldehyde: a new rapid fixation for electron microscopy.
        J. Cell Biol. 1967; 35: 148A
        • Adeghate E.
        • Donáth T.
        Morphometric and immunohistochemical study on the endocrine cells of pancreatic tissue transplants.
        Exp. Clin. Endocrinol. 1991; 98: 193-199
        • Papaccio G.
        • Mezzogiorno M.
        Morphological aspect of glucagon and somatostatin islet cells in diabetic bio breeding and low-dose streptozotocin-treated Wistar rats.
        Pancreas. 1992; 4: 289-294
        • Pons P.
        • Aoki A.
        Differential proliferation of somatostatin and glucagon cells in rat pancreatic islets submitted to different stimuli.
        Ann. Anat. 1995; 177: 221-227
        • Wang R.N.
        • Bonwens L.
        • Klöppel G.
        Beta cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity.
        Diabetologia. 1994; 37: 1088-1096